What is LOPJLB’s current signal on MLYS?

LOPJLB’s latest quantitative signal on Mineralys Therapeutics, Inc. (MLYS) is SELL in a CRISIS regime. Signals are updated daily.

What market regime is MLYS in?

Mineralys Therapeutics, Inc. (MLYS) is currently classified in the CRISIS HMM market regime on LOPJLB.

What does Mineralys Therapeutics, Inc. (MLYS) do?

Mineralys Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing medicines to target diseases driven by abnormally elevated aldosterone. Its clinical-stage product candidate, lorundrostat, is a proprietary, orally administered, highly selective aldosterone synthase inhibitor that are initially developing for the treatment of cardiorenal conditions affected…